Volume : 13, Issue : 04, April – 2026

Title:

DRUG-INDUCED HYPOGLYCEMIA WITH ANXIETY SYMPTOMS FOLLOWING CHANGE IN DIABETES MANAGEMENT

Authors :

Palle Umamaheshwari* , Somasani Jyoshna, C.Rakesh Kumar,D Goutham

Abstract :

Hypoglycemia is a common complication of antidiabetic treatment, but it does not always present in a typical manner[1,2]. In some patients, the symptoms may resemble psychological conditions, which can lead to confusion in diagnosis[3,12]. We report the case of a 75-year-old male with a 35-year history of type 2 diabetes mellitus, who developed repeated episodes of hypoglycemia that mainly presented as anxiety.
He had been stable on long-term metformin hydrochloride therapy for many years[6]. Recently, his treatment was adjusted by reducing the metformin dose and adding glimepiride to improve blood glucose control[7]. Soon after this change, he began experiencing symptoms such as restlessness, sweating, palpitations, and a sudden feeling of fear, especially when he had not eaten for some time[5,8]. These episodes were initially thought to be anxiety-related[12]. However, on closer evaluation, his blood glucose levels were found to be low during these episodes, confirming hypoglycemia as the cause[2,10].
Recognizing the link between his symptoms and the recent change in medication was important[14]. The dose of glimepiride was reduced, and he was advised on regular meals and self-monitoring of blood glucose[1,8]. Following these measures, his symptoms resolved completely, and no further episodes were reported.

Cite This Article:

Please cite this article in press Palle Umamaheshwari et al., Drug-Induced Hypoglycemia With Anxiety Symptoms Following Change In Diabetes Management, Indo Am. J. P. Sci, 2026; 13(04).

REFERENCES:

1. American Diabetes Association. Standards of Medical Care in Diabetes—2023. Diabetes Care. 2023;46(Suppl 1):S1–S291.
2. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: A report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384–1395.
3. Cryer PE. Hypoglycemia in Diabetes: Pathophysiology, Prevalence, and Prevention. 3rd ed. Alexandria, VA: American Diabetes Association; 2016.
4. Kalra S, Mukherjee JJ, Venkataraman S, Bantwal G, Shaikh S, Saboo B, et al. Hypoglycemia: The neglected complication. Indian J Endocrinol Metab. 2013;17(5):819–834.
5. Hepburn DA, Deary IJ, Frier BM, Patrick AW, Quinn JD, Fisher BM. Symptoms of acute insulin-induced hypoglycemia in humans with and without IDDM. Factor-analysis approach. Diabetes Care. 1991;14(11):949–957.
6. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach. Diabetes Care. 2015;38(1):140–149
7. Odegard PS, Setter SM, Iltz JL. An update in the pharmacologic treatment of type 2 diabetes mellitus: Impact on cardiovascular risk factors. Cardiol Rev. 2006;14(4):177–185
8. Schopman JE, Simon ACR, Hoefnagel SJM, Hoekstra JBL, Scholten RJPM, Holleman F. The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: A systematic review and meta-analysis. Diabetes Metab Res Rev. 2014;30(1):11–22.
9. Briscoe VJ, Davis SN. Hypoglycemia in type 1 and type 2 diabetes: Physiology, pathophysiology, and management. Clin Diabetes. 2006;24(3):115–121.
10. Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes. Diabetes Care. 2005;28(5):1245–1249.
11. Alvarez Guisasola F, Tofé Povedano S, Krishnarajah G, Lyu R, Mavros P, Yin D. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10(Suppl 1):25–32.
12. Pelletier AL, Butler AM, Gillies RA, Patel F. Anxiety and hypoglycemia: Overlapping symptoms and diagnostic confusion. Prim Care Companion J Clin Psychiatry. 2006;8(4):235–239.
13. Holstein A, Plaschke A, Egberts EH. Clinical characterisation of severe hypoglycaemia: A prospective population-based study. Exp Clin Endocrinol Diabetes. 2003;111(6):364–369.
14. Marks V, Teale JD. Drug-induced hypoglycemia. Endocrinol Metab Clin North Am. 1999;28(3):555–577.
15. Feldman-Billard S, Massin P, Meas T, Guillausseau PJ, Héron E. Hypoglycemia-induced blood pressure elevation in patients with diabetes. Arch Intern Med. 2010;170(9):829–831.
16. Punthakee Z, Goldenberg R, Katz P. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes. 2018;42(Suppl 1):S10–S15.
17. Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363(15):1410–1418.
18. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med. 1997;157(15):1681–1686.
19. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002–2012
20. Corriere M, Rooparinesingh N, Kalyani RR. Epidemiology of diabetes and diabetes complications in the elderly. Curr Diab Rep. 2013;13(6):805–813.
21. Munshi MN. Cognitive dysfunction in older adults with diabetes: What a clinician needs to know. Diabetes Care. 2017;40(4):461–467.
22. Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, et al. Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med. 2007;147(6):386–399.
23. Leese GP, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W, et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes. Diabetes Care. 2003;26(4):1176–1180.
24. Chisholm-Burns MA, Kim Lee J, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, et al. US pharmacists’ effect as team members on patient care: Systematic review and meta-analyses. Med Care. 2010;48(10):923–933.
25. Cigolle CT, Langa KM, Kabeto MU, Tian Z, Blaum CS. Geriatric conditions and disability: The Health and Retirement Study. Ann Intern Med. 2007;147(3):156–164.
26. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26(6):1902–1912.
27. Quilliam BJ, Simeone JC, Ozbay AB, Kogut SJ. The incidence and costs of hypoglycemia in type 2 diabetes. Am J Manag Care. 2011;17(10):673–680.